[Genetic Diagnostics in Everyday Clinical Practice in Child and Adolescent Psychiatry: Indications, Framework Conditions, Hurdles, and Proposed Solutions]

Genetic Diagnostics in Everyday Clinical Practice in Child and Adolescent Psychiatry: Indications, Framework Conditions, Hurdles, and Proposed Solutions Abstract: Health insurance covers medically necessary genetic testing in Germany. Diagnostic genetic testing has become increasingly important for child and adolescent psychiatry (CAP), reflected by the rising number of national guidelines relevant to CAP, including genetic testing in the recommended diagnostic work-up. However, implementation of theses guidelines in routine clinical care is lacking. This article provides a concise overview of the relevance of genetic testing in CAP-related national guidelines. It outlines the legal and financial framework for genetic testing in Germany. Furthermore, it points out barriers to implementation and offers potential solutions. It then provides examples from clinical practice highlighting the potential benefits patients and their family members might have from receiving a genetic diagnosis. The article closes by outlining future CAP-relevant areas in which genetic testing may become clinically relevant.

[Applicability of the SON-R 2-8 in Children with Special Educational Needs and Children with German as a Second Language]

Applicability of the SON-R 2-8 in Children with Special Educational Needs and Children with German as a Second Language The SON-R 2-8 is an intelligence test that allows a non-verbal assessment of the general cognitive abilities of children with difficulties or limitations in the field of speech and language development and communication. The validity of the SON-R 2-8 in children with cognitive impairments and children with German as a second language is examined with matched groups. It is shown that the SON-R 2-8 can differentiate well between normal children and cognitive impaired children and is suitable for use in children with German as a second language.

[Clinical diagnostics of psycho-social and cognitive standard of performance in youth with mental disabilities.]

Clinical diagnostics of psycho-social and cognitive standard of performance in youth with mental disabilities. Abstract. The clinical diagnostics of cognitive limitations and the resulting problems of social development occurring in childhood and adolescence are essential for further stimulation as well as for possible treatment strategies for comorbid mental diseases. This complex process should be carried out on several levels and with different methods. The resulting praxis-oriented question is defined via the pros and cons of the current procedure for the recording of psycho-social and cognitive stage of development of young people with mental disabilities. The online-based research in relevant databases was conducted systematically and yielded 3,324 articles. After fully reviewing the disqualifying criteria, 30 procedures remained. Twenty-four procedures could be assigned to "tests of development and intelligence" and six to "observer rating and self-report methods". It becomes clear that the majority of treatments have been standardized for children and adolescents of average intelligence. Meaning, only inaccurate information regarding the participation of children and adolescents with intelligence impairments in the standardized sample were given. This goes hand in hand with qualifying criteria that were not tested in consideration of the needs of people with intelligence impairment. Despite the current unsatisfactory situation, there is a demand for diagnostic instruments of the psycho-social and cognitive standard of performance in youth with mental disabilities. Currently, K-ABC II and ADOS-2 are recommended in combination with the observer rating methods ADI-R, VFE, and SRS.

[A Multi-arm Placebo-controlled Study with Glutamic Acid Conducted in Rostock in 1953/1954]

A Multi-arm Placebo-controlled Study with Glutamic Acid Conducted in Rostock in 1953/1954 Glutamic acid was commonly used in the treatment of intellectually disabled children in the 50s. Koch reported first results of an observation of 140 children treated with glutamic acid in 1952. In this line is the multi-arm placebo-controlled study reported here. The original study protocols were available. 58 children with speech problems who attending a school of special needs received glutamic acid, or vitamin B, or St.-John's-wort. The effect of glutamic acid was in few cases an improvement of attention. On the other hand restlessness and stutter increased. The majority of all reported a weight loss. The treatment with vitamin B showed a positive effect concerning concentration. The treatment with St.-John's wort was stopped caused by headache and vomiting in eight of nine cases. The results of the study reported here are unpublished. The reason may be that until the 60s the effects of glutamic acid in the treatment of intellectually disabled children were in generally overestimated.